Ayana Jordan, MD, PhD, Project/Medical Director
Dr. Jordan completed an MD, PhD program at Albert Einstein College of Medicine of Yeshiva University. She completed a general adult psychiatric residency and addiction psychiatry fellowship at Yale University, where she served as Program-Wide Chief. Currently, Dr. Jordan is an assistant professor at Yale and a physician attending at Connecticut Mental Health Center. She is committed to increasing access to addiction services within minority communities, both nationally and abroad. Dr. Jordan has done research in Sierra Leone, West Africa examining the link between, mental illness, substance use and stigma, and has served as an expert witness discussing these issues. In Connecticut, Dr. Jordan is working with Black churches to offer evidenced based interventions for substance use. Dr. Jordan is the proud recipient of various clinical and research awards and was recently inducted into the Top 40 under 40 Society by her undergraduate alma mater.
Jeanette M. Tetrault, MD, FACP, FASAM, Assistant Medical Director
Dr. Tetrault is an Associate Professor of Medicine in the Section of General Internal Medicine at Yale School of Medicine. She is the founding Program Director for the Yale’s Addiction Medicine Fellowship. She is a primary care physician and addiction medicine specialist at the APT Foundation, where she provides primary care services, chronic disease management, including HIV and Hepatitis C treatment; and addiction specialty care including methadone, buprenorphine and naltrexone treatment. She co-directs the Addiction Recovery Clinic, a specialty clinic embedded within the residency continuity practice, which serves a dual clinical and educational mission. She is on the Board of Directors of the Addiction Medicine Foundation and the Addiction Medicine Fellowship Director’s Association. She is co-chair of the Society of General Internal Medicine’s (SGIM) Alcohol, Tobacco and Other Drug Use Interest Group, and past- president for the New England Region of SGIM. Her academic interest focuses on improving care of patients with substance use and the chronic diseases associated with addiction. She is recognized as a Macy Foundation Faculty Scholar for her work expanding addiction medicine curricula for health professions students at Yale. Dr. Tetrault has published widely in the field of Addiction Medicine including epidemiologic investigation, investigation of unique delivery care models, examination of safety of addiction pharmocotherapies, and addiction medicine curriculum design, evaluation, and dissemination.
Kathryn Cates-Wessel, PI
Ms. Cates-Wessel has more than 30 years of background and experience in the substance use disorder field in administration, medical education, and policy. She is Chief Executive Officer of the American Academy of Addiction Psychiatry (AAAP) and Principal Investigator and Project Director for both the PCSS and STR-TA grant. As Principal Investigator and Project Director of these projects, she oversees the overall administration of the projects staff; consultants and sub-awards; negotiating contracts and overseeing work of partner organizations, consultants and vendors; and ensuring that all aspects of this these projects are undertaken according to the project plans. Prior to her work at AAAP, she was Associate Director of Brown University's Center for Alcohol and Addiction Studies for over 19 years and Executive Director of Physicians and Lawyers for National Drug Policy, a think tank of leaders from law and medicine advocating for prevention/treatment of addicts over incarceration. Prior to that she was Associate Director of a residential treatment center for adolescents for substance use disorders and co-occurring mental disorders.
Katie Clark, MSPH, CADC, Project Evaluator
Ms Clark is a Research Consultant at Clark Health Education and Research Solutions, LLC. She provides research consultation services to academic institution, hospitals, non-profit community-based organizations, and state and local governments. Katie specializes in research design and program evaluation that uses both quantitative and qualitative approaches. She is a doctoral student in Translational Health Sciences at George Washington University and her dissertation topic is focused on successful buprenorphine/naloxone implementation in Connecticut. Katie earned her Master of Science in Public Health and a Certificate in Survey Methodology from UNC Chapel Hill. She completed her undergraduate studies at Godard College with a focus on pregnancy and substance use, public health and audio journalism.
Dafna Paltin, Program Manager
Dafna received her BS from Temple University in Philadelphia, PA, where she majored in Neuroscience and double minored in Psychology and Art History. Both minors informed her major in that she was exploring how neuroscience is integrated into other social and cultural domains. Dafna is inspired by interdisciplinary approaches to complex health problems, and has had the privilege of working closely with several nationally recognized scientists and mentors known for innovations in their fields. It was while working in a neurorehabilitation laboratory at the University of Wisconsin that Dafna became aware of the complex patient-provider communication gaps that exist, particularly for underserved and marginalized populations (i.e. people of color, LGBTQ+, and individuals with disabilities). Her consistent desire to be at the vanguard of research and clinical interventions has lead Dafna to the work of Dr. Ayana Jordan at Yale University. As the REACH Project Manager, Dafna aims to draw attention to the unique medical and mental health needs of under-represented minority patients with substance use disorder. From this vantage point, Dafna intends to draw attention to the issues that are often overlooked in patient care, and create reform around clinical practices.
- Advisory Board
REACH Advisory Board
The Advisory Board, with members recruited outside of Yale, consists of a diverse panel of experts (experts from various disciplines and community members), with collective international and national experience in both addiction education and reducing behavioral health disparities among racial and ethnic minority populations. Through these partnerships, the REACH program creates a support network specifically designed to increase capacity of culturally-informed physicians, while also increasing the recruitment of trainees from URM backgrounds, who are able to meet the unique needs of URM PWSUD.
Dr Adger is Professor of Pediatrics at the Johns Hopkins University School of Medicine and Director of Adolescent Medicine at the Johns Hopkins Hospital. He has served as Director of the Substance Abuse Assessment/Intervention Team at The Johns Hopkins Hospital Adolescent Program and previously served as Director of The Johns Hopkins Substance Abuse Faculty Development Program. A major focus of Dr. Adger’s research and professional interests has been in the area of substance abuse education for health professionals. He has become nationally recognized for his work in developing substance abuse curricula and clinical practice standards for health professionals. In 1997-98 he served as Deputy Director of the White House Office of National Drug Control Policy and is previous Co-Director of the Strategic Planning Initiative funded by HRSA to advise the federal government and others on improving and expanding interdisciplinary education and training of health professionals in substance use disorders. He is currently PI and Project Director of the HRSA funded Leadership Education in Adolescent Health project at the Johns Hopkins Hospital and Faculty Leader of the Florence Sabin College in the Johns Hopkins School of Medicine. He is a Diplomate of and serves as the Pediatric Discipline Director for the American Board of Addiction Medicine Foundation.
Adina E. Bowe, MD
Adina E. Bowe is currently an Assistant Professor in Internal Medicine and Psychiatry at West Virginia University Charleston Division. She is board certified in Internal Medicine, Psychiatry and Addiction Psychiatry. Her special interests reside in treating medically complexed, dually diagnosed individuals with addiction disorders in rural communities. She is an advocate for the integrated care model of health delivery. Dr. Bowe is an active member of American Academy of Addiction Psychiatry, the American Medical Association and the American Psychiatric Association. In her spare time she enjoys visiting her family in the Bahamas, hiking and kayaking.
Andrew Danzo is Director of Fellowship Development for The Addiction Medicine Foundation (TAMF). He has been involved in developing fellowship training programs since 2010 as part of the successful effort to build a graduate medical education infrastructure for Addiction Medicne and achieve its formal recognition by the American Board of Medical Specialties and the Accreditation Council for Graduate Medical Education. Based in the Department of Family Medicine at the University at Buffalo Jacob School of Medicine and Biomedical Sciences, Mr. Danzo has also worked on a variety of projects, including faculty development the New York State Rural Health Research Center and New York State Area Health Education Center. From 2000-2009, he served as Associate Editor of the Journal of Rural Health, the premiere peer-reviewed publication focused on healthcare access and related issues for the nation’s nonmetropolitan population. He earned a BA in economics and political science from Rutgers University and previously worked for a number of years as a journalist.
Patrick Dowling, MD, MPH
Dr. Patrick Dowling is Kaiser Endowed Professor of Community Medicine and Chair of the UCLA Department of Family Medicine (UDFM). A graduate of the Medical College of Ohio, he completed his residency training in Family Medicine at Cook County Hospital in Chicago and earned an MPH at Michigan. He is board certified in Family Medicine, Preventive Medicine/Public Health. The UDFM sponsors a Family Medicine residency as well as fellowships in Sports Medicine and Addiction Medicine. Further, UDFM operates a large NIH- funded program in partnership with universities in S. Africa and Vietnam to address substance abuse and HIV, and is assisting the health ministry of Mozambique in developing Family Medicine.
After completing training in Chicago, he served as medical director at migrant health centers for three years with Cesar Chavez on the rural Mexican-Californian border. He then returned to Cook County Hospital and for seven years, served as Associate Chair of Family Medicine, followed by three years as Program Director at Brown University. Prior to joining UCLA as chair of the UDFM in 1998, he served as Chair of Family Medicine at Harbor-UCLA for nine years.
His professional interests include health policy, the provision of care to under-resourced communities and the linkage of graduate medical education to underserved communities as a means to improve access and reduce health outcomes disparities. Moreover, his research interests include cross cultural and bi-national medicine and the integration of behavioral medicine and substance abuse treatment within primary care.
CDR Karen Hearod is a Licensed Clinical Social Worker and a member of the Choctaw Nation of Oklahoma. Prior to accepting her new role as Regional Administrator, CDR Hearod served as the Indian Health Service Oklahoma City Area Acting Behavioral Health Consultant. In this position CDR Hearod had oversight over behavioral health and substance abuse programs across Oklahoma, Texas, and Kansas providing services impacting 410,00 Native Americans. In addition to providing leadership as Chair for the IHS National Zero Suicide Advisory Committee, she served as a member of the National Suicide Crisis Policy Committee working to establish the first IHS national suicide care policy.
During her federal career, CDR Hearod has served as the Chief Behavioral Health Officer for the Choctaw Nation of Oklahoma. In this role, Hearod oversaw a behavioral health system which spanned the area equivalent to the size of Vermont including 13 facilities and 90 staff. She was successful in seeking out and implementing multiple grants addressing substance abuse and suicide prevention, sexual assault forensic treatment and prevention, HIV and teen pregnancy prevention, and cardiovascular disease prevention. She led the creation of the Choctaw Nation Wind Horse Treatment Center providing family centered substance abuse prevention and treatment services for high risk families in an area with little access to care. She also facilitated the transition to a fully integrated Electronic Health Record for Behavioral Health with Choctaw Nation Health programs greatly improving continuity of care.
Kevin Kunz, MD, MPH, DFASAM
Since 2013, Dr. Kunz has been the Executive Vice President of the American Board of Addiction Medicine (ABAM) and The American College of Academic Addiction Medicine (ACAAM, formerly the Addiction Medicine Foundation) and previously served as President of both. He is a graduate of the University of Hawaii’s John A. Burns School of Medicine, and serves now on that clinical faculty. Dr. Kunz has practiced primary care and Addiction Medicine in Hawaii for 40 years. Under his executive leadership at ABAM and ACAAM over 4,000 physicians have received national certification in Addiction Medicine. The field of Addiction Medicine gained recognition by the ABMS and the ACGME, resulting in 62 one-year Addiction Medicine Fellowships being established and accredited. Dr. Kunz has authored or co-authored multiple journal articles in the field of Addiction Medicine, and is a Section Editor for the field’s primary text, “Principles of Addiction Medicine”. In the recently published 6th Edition of this text, he authored a chapter entitled “The Addiction Medicine Physician as a Change Agent for Prevention and Public Health”. Dr. Kunz has had a career interest in issues of interdisciplinary care and the provision of equitable care to underserved populations. Since 2014, he has been the PI on a $3.5 Million Addiction Medicine workforce development grants from philanthropic and governmental sources.
Dr. Kunz has received recognition for his local, state and national work in addiction prevention and treatment. He has been a recipient of: the AMERSA John P. McGovern Award for Excellence in Medical Education; Clinician of the Year Award from the Hawaii Medical Association; Outstanding Service Award- Hawaii Island Rural Health Association; the Governor’s Kilohana Award for Outstanding Volunteerism; and the Annual Award of the American Society of Addiction Medicine among others. Dr. Kunz is focused on expanding the Addiction Medicine physician workforce and the development of fellowship training programs for the purpose of bringing evidence informed prevention and treatment to patients, families and health care systems.
Paula J. Lum, MD MPH is Professor of Clinical Medicine and Program Director of the UCSF Primary Care Addiction Medicine Fellowship. She has been a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at San Francisco General Hospital since 1999. Board certified in internal medicine and addiction medicine, Dr. Lum practices at the place where HIV, addiction, and poverty collide. Her research and clinical activities are grounded in evidence-based, patient-centered care to improve health outcomes and life quality of the urban poor. Her current areas of focus include: (1) HIV and viral hepatitis prevention and treatment in persons who inject drugs, (2) evidence-based interventions in primary care and non-traditional settings for substance use disorders and their complications, and (3) curricular interventions to provide health care professionals with the skills, knowledge, and confidence to offer effective patient-centered care to persons who use drugs.
Ismene Petrakis, MD
Dr. Ismene Petrakis is Professor of Psychiatry at the Yale University School of Medicine and the Chief of Psychiatry and Mental Health Services at VA Connecticut Healthcare System. She is also the Director of the Addiction Psychiatry Residency at Yale University School of Medicine, the principal investigator of a National Institute of Drug Abuse (NIDA-T32) training grant. She is involved in the education of medical students and residents at many stages of their training, particularly around clinical issues of addictive disorders. She is also a grant funded investigator (funding sources over the years have included NIH, VA, Department of Defense, NARSAD and the Stanley Foundation) whose research interests include developing an understanding of the neurobiology of alcohol dependence and in testing potentially effective treatments for individuals with alcohol dependence and comorbid Axis I psychiatric disorders.
Dr. Petrakis received her undergraduate degree at Northwestern University and her medical training at the University of Pittsburgh, School of Medicine. She completed her residency training at Yale University School of Medicine and then completed an Addiction Psychiatry Fellowship, also at Yale University. Since completing her training, Dr. Petrakis has over 20 years of experience in the clinical treatment of addictive disorders, research in this field and in the education of residents, medical students, post-doctoral fellows and other mental health trainees in the assessment, accurate diagnosis and treatment of patients with addictive disorders.
Richard Schottenfeld, Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Howard University College of Medicine: A leading clinical researcher, educator, and developer of clinical programs and services, Dr. Schottenfeld has played a key role in development and expansion of primary care-based treatments for opioid use disorder in the U.S. and internationally. He has directed training programs in Addiction Psychiatry and drug abuse clinical research and an interdisciplinary faculty development program for faculty in Internal Medicine, Obstetrics and Gynecology, Pediatrics, and Psychiatry who have subsequently played major roles in developing drug abuse clinical research and training programs.
Olapeju Simoyan, MD, MPH, BDS, FAAFP
Dr Simoyan is the program director for the addiction medicine fellowship at Geisinger Marworth Treatment Center in Waverly, Pennsylvania. She is also an associate professor of Family Medicine and Epidemiology at the Geisinger Commonwealth School of Medicine in Scranton PA and serves on the American Board of Preventive Medicine’s sub-committee on addiction medicine. Dr Simoyan earned a dental degree from the University of Ibadan in Nigeria, a Master of Public Health degree from the Johns Hopkins University Bloomberg School of Public Health and a medical degree from Penn State University College of Medicine in Hershey, PA. She completed an internship in psychiatry/family medicine at the University of Pittsburgh Medical Center/Western Psychiatric Institute and completed her family medicine residency at the Penn State/Good Samaritan Hospital Family and Community Medicine Residency program. Dr Simoyan is board certified in addiction medicine, family medicine and dental public health. She has contributed to international public health education as a Fulbright specialist in Nigeria and an Erasmus Mundus scholar in France and the U.K. She has also volunteered on medical mission projects in Nigeria and Haiti with humanitarian organizations including Pro - Health International and FaithCare, Inc.
Dr Simoyan’s numerous scholarships and awards include the Emerging Leader award from the Family Medicine Education Consortium (2010) and the American Association of Medical College’s Herbert Nickens Faculty Fellowship (2012). She was recognized by the Northeastern Pennsylvania Business Journal as one of the Top 25 Women in Business in 2015 and she was a second prize winner in the State Department’s Citizen Diplomacy Challenge in the same year.
In her spare time, she enjoys spending time with family and friends, travel, writing, photography and playing various musical instruments.